SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): June 3, 2003
VENTIV HEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)
DELAWARE
(State or Other Jurisdiction of Incorporation)
0-30318 | | 52-2181734 |
(Commission File Number) | | (I.R.S. Employer Identification No.) |
VANTAGE COURT NORTH
200 COTTONTAIL LANE
SOMERSET, NEW JERSEY 08873
(Address of Principal Executive offices) (Zip Code)
(800) 416-0555
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if changed Since Last Report)
VENTIV HEALTH, INC.
CURRENT REPORT ON FORM 8-K
Item 5. Other Events and Regulation FD Disclosure.
On June 3, 2003, Ventiv Health, Inc. (the “Company”), issued a press release announcing that its French subsidiaries have been placed into receivership. A copy of the Company’s press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
Exhibit Number | | Description of Exhibit |
|
99.1 | | Press Release of Ventiv Health, Inc. dated June 3, 2003 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | VENTIV HEALTH, INC. |
|
| | | By:/s/ JOHN R. EMERY |
Date: June 5, 2003 | | Name: John R. Emery |
| | | Title: Chief Financial Officer |
EXHIBIT INDEX
Exhibit Number | | Description of Exhibit |
|
99.1 | | Press Release of Ventiv Health, Inc., dated June 3, 2003 |
